On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

DGE’s 4th Aligning Drug Safety Functions & REMS Summit: A Groundbreaking Event for Patient Safety

Pharma, biotech, medical device, healthcare, and regulatory professionals are gathering for the 4th Aligning Drug Safety Functions & REMS Summit, taking place on August 29-30, 2023, at The Inn at Penn in Philadelphia, PA.

Set to take place in the beautiful city of Philadelphia, the conference will delve into the latest insights and address the most critical challenges surrounding drug safety and REMS (Risk Evaluation & Mitigation Strategy).

As the only event that brings together drug safety, pharmacovigilance, and risk management teams—no other conference provides as much detail and comprehensive insights into communication strategies among safety teams, prioritizing patient safety, and preparing for pharmacovigilance and REMS inspections. Attendees will walk away armed to effectively up their game and amplify patient feedback and participation in REMS programs.

Interactive and Inspirational Discussions!

With a well-rounded agenda focused on the latest advances in drug safety and REMS space, the program is designed to provide attendees with all the tools they need to develop and implement a robust global risk management plan.

Featuring interactive discussions, such as exploring the critical intersection of REMS and pharmacovigilance in shared REMS systems, discovering the power of AI to optimize REMS implementation, strategies to improve signal management and detection, fortifying compliance and quality in post-approval studies. Delve into the cutting-edge realm of patient-centricity for benefit-risk assessment and their implications for the future of healthcare.

Throughout the two-day summit, attendees will be able to connect with an outstanding lineup of expert speakers and industry leaders and learn network, and interchange ideas and innovative approaches surrounding drug safety and REMS strategies to better support patient safety.

Sign up and forge a safer and more patient-centric future at the most trusted drug safety event. Interested participants can register for this summit and secure their tickets at early-bird prices.

To learn more, please visit https://nnw.fm/uBCbG.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)waa
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork


Select A Month

NetworkNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 212.418.1217